Stockreport

Chief Medical Officer Jared Gollob Sells 46,137 Shares of Kymera Therapeutics Inc [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF to a recent SEC Filing . Kymera Therapeutics Inc is a biotechnology company focused on discovering and developing small molecule therapeutics that selectively degrade di [Read more]